Clinical Trials Arena on MSN
Psyence gains HREC nod to use PsyLabs’ psilocybin in adjustment disorder trial
With several sites activated and recruitment ongoing, the Phase IIb trial is projected to deliver top-line outcomes next year ...
The Bellberry Human Research Ethics Committee formally approved the use of PsyLabs’ psilocybin formulation (NPX5) in Psyence’s clinical trial evaluating psilocybin-assisted psychotherapy for ...
The SPONTAN Phase 2 clinical trial, approved by the Bellberry Human Research Ethics Committee, is designed to evaluate both single and multiple doses of an innovative intranasal therapy. This study ...
Radiopharm Theranostics Ltd. has been granted Bellberry Human Research Ethics Committee (HREC) approval in Australia to initiate a first-in-human phase I trial of its KLK3-targeting radiotherapeutic, ...
Rona Therapeutics Co. Ltd. has announced the submission of RN-5681 to the Australian Human Research Ethics Committee (HREC), and anticipates dosing to begin in a phase I trial in the first quarter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback